Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY) - Concepedia

Concepedia

Publication | Open Access

Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)

DOI Full Paper Access

51

Citations

21

References

2018

Year

Stanley Cohan, Harold Moses, Jonathan Calkwood, Carlo Tornatore, Chris LaGanke, Kyle Smoot, Venkata Srikanth Meka, Macaulay Okwuokenye, Christophe Hotermans, Jason P. Mendoza,

Multiple Sclerosis and Related Disorders

Abstract

ClinicalTrials.gov identifier NCT02159573.

References

	Year	Citations

Page 1